[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 288
Citations 0
Comment & Response
August 2016

How Similar Are the Disorders Included Under the Umbrella of Obsessive-Compulsive Disorder and Related Disorders?—Reply

Author Affiliations
  • 1Department of Psychiatry and Behavioral Neuroscience, Pritzker School of Medicine, University of Chicago, Chicago, Illinois
  • 2Department of Psychiatry, University of Cambridge, Cambridge, England
  • 3Cambridge and Peterborough NHS Foundation Trust, Cambridge, England

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Psychiatry. 2016;73(8):877-878. doi:10.1001/jamapsychiatry.2016.1452

In Reply Costa and colleagues raise important issues regarding how grooming disorders (GDs) should be optimally treated and classified.

N-acetylcysteine (NAC) showed superiority over placebo as monotherapy in excoriation disorder,1 similar to findings in trichotillomania. However, NAC’s findings in obsessive-compulsive disorder (OCD) are mixed. Two clinical trials reported significant benefits of NAC augmentation over placebo for OCD,2,3 while a third study did not show benefits over placebo.4 As Costa and colleagues suggest, differential pharmacological response across disorders is an important factor when considering diagnostic classification. This is also complicated by differences in study designs, as results may vary when using NAC as augmentation to a selective serotonin reuptake inhibitor rather than a primary intervention.